Abilify Co-Defendant Says It Can’t Be Sanctioned For Deleting Emails Before Suits
PENSACOLA, Fla. — Abilify co-marketer Otsuka American Pharmaceutical Inc. (OAPI) on Feb. 22 told a Florida multidistrict litigation judge that it should not be sanctioned for discovery violations because it had...To view the full article, register now.
Already a subscriber? Click here to view full article